Welcome to our dedicated page for Unitedhealth Gp news (Ticker: UNH), a resource for investors and traders seeking the latest updates and insights on Unitedhealth Gp stock.
UnitedHealth Group (NYSE: UNH) is a global leader in healthcare services and insurance, driving innovation through its UnitedHealthcare and Optum divisions. This page serves as the definitive source for all official company announcements, providing investors and stakeholders with timely access to critical developments.
Track UNH's financial performance through quarterly earnings reports, analyze strategic moves via merger/acquisition updates, and stay informed on regulatory filings shaping the healthcare landscape. Our curated collection includes press releases on partnerships, technology initiatives, and operational milestones directly from UnitedHealth Group.
Key updates cover Medicare/Medicaid program changes, prescription drug benefits innovations, and value-based care advancements through Optum's data-driven solutions. Bookmark this page for real-time access to primary source materials that impact market analysis and long-term strategic evaluation in the managed care sector.
UnitedHealth Group (NYSE: UNH) announced that Scott Gottlieb, M.D., former FDA commissioner, joined its Board of Directors effective November 18, 2025. Dr. Gottlieb served as FDA commissioner from 2017–2019 and is noted for initiatives on transparency, patient safety, pharmaceutical competition, opioid response, and youth tobacco prevention.
He has held roles at CMS and the Federal Health IT Policy Committee, is a practicing physician and National Academy of Medicine member, and holds positions at the American Enterprise Institute and New Enterprise Associates. UnitedHealth said it expects his expertise to inform innovation, affordability, and care delivery across its Optum and UnitedHealthcare businesses.
UnitedHealth Group (NYSE: UNH) announced the board authorized a cash dividend of $2.21 per share. The dividend will be paid on December 16, 2025 to shareholders of record at the close of business on December 8, 2025.
UnitedHealth Group operates two complementary businesses: Optum (care, technology, data) and UnitedHealthcare (health benefits). Contact details for investors and media were provided.
UnitedHealth Group (NYSE: UNH) reported Q3 2025 revenues of $113.2 billion, up 12% year-over-year, and raised full-year 2025 guidance to at least $14.90 GAAP EPS and $16.25 adjusted EPS. Q3 adjusted EPS was $2.92 (GAAP EPS $2.59). Cash flow from operations was $5.9 billion (2.3x net income). Medical care ratio rose to 89.9% and consolidated earnings from operations declined to $4.3 billion.
UnitedHealthcare (NYSE:UNH), the nation's largest Medicare Advantage carrier, has unveiled its 2026 Medicare Advantage plans, maintaining coverage accessibility for 94% of Medicare-eligible individuals. The company is focusing on preserving affordable access despite programmatic funding cuts, with most beneficiaries having access to $0 premium plans.
Key features include $0 copays for preventive care, primary care visits, lab work, and Tier 1 prescriptions at network pharmacies. The company is expanding its HMO plans to reach 92% of eligible beneficiaries, D-SNPs to 80% of dual eligibles, and C-SNPs offering specialized benefits for chronic conditions. UnitedHealthcare was recently named the Best Insurance Company for Medicare Advantage 2025 by U.S. News & World Report.
UnitedHealth Group (NYSE: UNH) has scheduled its Q3 2025 earnings release for Tuesday, October 28, 2025, before market opening. The company will host an analyst and investor teleconference at 8:00 a.m. ET on the same day.
The earnings call will be accessible via webcast on UnitedHealth Group's Investor Relations website, with a replay available through November 11. The company operates through two main segments: Optum, which provides technology-driven healthcare solutions, and UnitedHealthcare, which offers comprehensive health benefits and coverage services.
AM Best has downgraded UnitedHealth Group (NYSE: UNH) and its subsidiaries' credit ratings, reflecting significant deterioration in operating performance. The Long-Term Issuer Credit Rating was lowered to "a-" from "a", while UnitedHealthcare's Financial Strength Rating was reduced to A (Excellent) from A+ (Superior).
The company expects $6.5 billion in additional medical expenses for 2025, with increased costs across all business lines, particularly in Medicare Advantage. Operating margins for the health insurance business are projected to be approximately 50% lower than 2024 levels. Despite challenges, UnitedHealth maintains strong balance sheet strength with risk-adjusted capital managed in the 225-250% range. The company's financial leverage stood at 44.1% as of Q2 2025, above its long-term target of 40%.
UnitedHealth Group (NYSE: UNH) has announced its board of directors has authorized a quarterly cash dividend of $2.21 per share. The dividend will be paid on September 23, 2025, to shareholders of record as of September 15, 2025.
UnitedHealth Group operates through two main business segments: Optum, which provides technology-enabled healthcare services, and UnitedHealthcare, which offers health benefits and insurance coverage. The company focuses on improving healthcare accessibility and quality while maintaining affordability.
UnitedHealth Group (NYSE: UNH) has announced significant changes to its leadership team. Wayne S. DeVeydt will become the company's new Chief Financial Officer effective September 2, 2025, succeeding John F. Rex, who will transition to the role of strategic advisor to the CEO.
DeVeydt, 55, joins UNH from Bain Capital where he served as managing director and operating partner. His extensive healthcare experience includes roles as Chairman and CEO of Surgery Partners (2018-2020) and CFO of Anthem (2007-2016). Rex, 63, who has been CFO since 2016, will continue supporting the leadership team in his new advisory capacity.
UnitedHealth Group (NYSE:UNH) has re-established its full year 2025 outlook, projecting revenues of $445.5-$448.0 billion and adjusted earnings of at least $16.00 per share. The company reported Q2 2025 revenues of $111.6 billion, up $12.8 billion year-over-year, with adjusted earnings of $4.08 per share.
The medical care ratio increased to 89.4%, up 430 basis points year-over-year, primarily due to medical cost trends exceeding pricing trends. Q2 results include $1.2 billion of unfavorable discrete impacts, with $620 million related to individual exchange business losses.
The company expects to return to earnings growth in 2026, with current challenges including higher-than-expected medical cost trends across UnitedHealthcare businesses and Medicare funding reductions. Medical cost trend in Medicare Advantage is projected to reach ~7.5% in 2025 and accelerate to nearly 10% in 2026.
UnitedHealth Group (NYSE: UNH) has rescheduled its second quarter 2025 financial results conference call to an earlier time. The teleconference will now begin at 8:00 a.m. ET on Tuesday, July 29, 2025, which is 45 minutes earlier than previously announced. The change aims to provide additional time for discussion with analysts and investors.
The earnings call will be accessible via webcast on UnitedHealth Group's investor relations website, with a replay available through August 12, 2025. The company will release its Q2 2025 financial results before the market opens on the same day.
FAQ
What is the current stock price of Unitedhealth Gp (UNH)?
What is the market cap of Unitedhealth Gp (UNH)?
